ELFY DIN 02553481
Health Canada record
| Active ingredient(s) | NORETHINDRONE ACETATE 1 MG; ETHINYL ESTRADIOL 10 MCG; ETHINYL ESTRADIOL 10 MCG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | G03AB04 NORETHISTERONE AND ESTROGEN |
| Original market date | 20-Apr-2026 |
| Current status date | 20-Apr-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Apotex Inc — licence 100375, currently licensed, last inspection rating C (2026-04-21).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing NORETHINDRONE ACETATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02417456 | LOLO | ABBVIE CORPORATION | Tablet | NORETHINDRONE ACETATE 1 MG; ETHINYL ESTRADIOL 10 MCG; ETHINYL ESTRADIOL 10 MCG | Marketed |
| 00023760 | NORLUTATE | SEARCHLIGHT PHARMA INC | Tablet | NORETHINDRONE ACETATE 5 MG | Marketed |
| 02242531 | FEMHRT | WARNER CHILCOTT CANADA CO | Tablet | NORETHINDRONE ACETATE 1 MG; ETHINYL ESTRADIOL 5 MCG | Cancelled Post Market |
| 00353027 | LOESTRIN 1.5/30 | ALLERGAN INC | Tablet | NORETHINDRONE ACETATE 1.5 MG; ETHINYL ESTRADIOL 30 MCG | Cancelled Post Market |
| 00315966 | MINESTRIN 1/20 | ALLERGAN INC | Tablet | NORETHINDRONE ACETATE 1 MG; ETHINYL ESTRADIOL 20 MCG | Cancelled Post Market |
| 00343838 | MINESTRIN 1/20 | ALLERGAN INC | Tablet | NORETHINDRONE ACETATE 1 MG; ETHINYL ESTRADIOL 20 MCG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 37364 | 2026-04-20 | Abbreviated New Drug Submission (ANDS) |
International API supply for NORETHINDRONE ACETATE
7 active FDA Drug Master Files.
Request a quote for ELFY